Abstract Vascular matrix remodeling occurs during development, growth, and several pathological conditions that affect blood vessels. We investigated the capacity of human smooth muscle cells (SMCs) to express matrix metalloproteinases (MMPs), enzymes that selectively digest components of the extracellular matrix (ECM), in the basal state or after stimulation with certain cytokines implicated in vascular homeostasis and pathology. Enzymatic activity associated with various proteins secreted in the culture media was detected by gelatin or casein sodium dodecyl sulfate-polyacrylamide gel electrophoresis zymography. Proteins were identified by immunoprecipitation and mRNA by Northern blotting. SMCs constitutively secreted a 72-kD gelatinase and the tissue inhibitors of MMPs (TIMPs) types 1 and 2. SMCs stimulated with interleukin-1 or tumor necrosis factor-a synthesized de novo 92-kD gelatinase, interstitial collagenase, and stromelysin. Several lines of evidence suggest that when stimulated by cytokines, SMCs produce activated forms of MMPs. Together, the constitutive and the cytokine-induced enzymes can digest all the major components of the vascular ECM. Moreover, since these mediators augment the production of MMPs without appreciably affecting the synthesis of TIMPs, locally secreted cytokines may tip the regional balance of MMP activity in favor of vascular matrix degradation. (Circ Res. 1994;75:181-189.) Key Words * matrix metalloproteinases * extracellular matrix * smooth muscle cells * cytokines * collagenase Smooth muscle cells (SMCs) are the major cell type of medium-and large-sized blood vessels. These cells synthesize important components of the extracellular matrix (ECM), including collagens, elastin, and proteoglycans. SMCs produce the bulk of the ECM of the vessels. However, knowledge of the capacity of SMCs to catabolize this matrix remains incomplete. Cell migration and proliferation, angiogenesis, and accumulation or resorption of ECM all depend on altered metabolism of its constituents. These cellular events occur during physiological processes such as morphogenesis, development, and growth, and in several pathological conditions.12 SMCs might contribute to remodeling of the blood vessel matrix, especially in situations in which these cells accumulate, including atheroma or lesions that form after vascular interventions.
Smooth muscle cells (SMCs) are the major cell type of medium-and large-sized blood vessels. These cells synthesize important components of the extracellular matrix (ECM), including collagens, elastin, and proteoglycans. SMCs produce the bulk of the ECM of the vessels. However, knowledge of the capacity of SMCs to catabolize this matrix remains incomplete. Cell migration and proliferation, angiogenesis, and accumulation or resorption of ECM all depend on altered metabolism of its constituents. These cellular events occur during physiological processes such as morphogenesis, development, and growth, and in several pathological conditions.12 SMCs might contribute to remodeling of the blood vessel matrix, especially in situations in which these cells accumulate, including atheroma or lesions that form after vascular interventions.
Enzymes that selectively digest the individual components of ECM are collectively called matrix metalloproteinases (MMPs) and belong to three main groups: the interstitial collagenases, the type IV collagenases or gelatinases, and the stromelysins.3 Reshaping of con-nective tissues occurring in inflammation, wound healing, or tumor invasion likely involves the action of various MMPs secreted by immune cells, fibroblasts, and tumor cells. 45 The enzymatic activity of MMP is regulated at several levels. Many growth factors, cytokines, hormones, or tumor promoters regulate MMP expression at the transcriptional level. 6 All secreted MMP zymogens require proteolytic processing to exert their matrix-degrading potential,7 a posttranslational control mechanism. The balance between MMPs and their natural inhibitors, called the tissue inhibitors of MMPs (TIMPs), further modulates the enzymatic activity of MMPs.
Previous studies of MMP production by vascular cells have often dealt with microvascular endothelial cells, whose capacity to produce matrix-degrading enzymes appears crucial in angiogenesis.89 In normal and diseased aortic tissue, the 92-kD gelatinase (also called MMP-9, type V gelatinase, or gelatinase B) and TIMP-1 localize preferentially within the adventitia.10 Explants of the tunica media of rabbit aorta secrete the 72-and 92-kD gelatinases but reportedly not interstitial collagenase or stromelysin.1" Others12 have found that human SMCs can produce interstitial collagenase (or MMP-1) when stimulated by platelet-derived growth factor (PDGF), interleukin-1 (IL-1), or the tumor promoter tetradecanoylphorbol acetate (TPA), in addition to a constitutive secretion of 72-kD gelatinase (also called MMP-2, type IV gelatinase, or gelatinase A). As in the case of rabbit aortic explants,11 the latter group also failed to detect production of stromelysin (MMP-3) by human SMCs. 12 Although such reports have estab- lished that SMCs can express certain members of the MMP family, the ability of these cells to secrete the whole spectrum of MMP and to produce active forms required for vascular matrix remodeling remains uncertain. Knowledge of the expression of endogenous inhibitors of MMP (TIMPs 1 and 2) by SMCs is also lacking. Therefore, we investigated the capacity of SMCs to produce MMPs and TIMPs under basal conditions and examined their regulation by certain cytokines potentially relevant to vascular pathobiology.
Materials and Methods

Antibodies
We used rabbit polyclonal antibodies raised against recombinant human collagenase, stromelysin (or MMP-3), and TIMP-1. 
Zymography
Proteins with gelatinolytic or caseinolytic activity were identified by electrophoresis in the presence of sodium dodecyl sulfate (SDS) in 10% or 12% discontinuous polyacrylamide gels containing 1 mg/mL gelatin or casein.8 Culture media were loaded on gels either directly or after immunoprecipitation with specific antibodies. After electrophoresis, the proteins in the gels were renatured by exchanging SDS with Triton X-100 (two 15-minute incubations in 2.5% Triton X-100). Gels were subsequently incubated overnight at 37°C in 50 mmol/L Tris-HCl, pH 7.4, containing 10 mmol/L CaCl2 and 0.05% Brij 35 (Sigma). To verify the MMP nature of the lytic activity detectable by zymography, identical gels were incubated in the above buffer containing either 20 mmol/L EDTA, an inhibitor of MMP, or 1 mmol/L phenylmethysulfonyl fluoride (PMSF), an inhibitor of serine proteases. At the end of incubation, gels were stained with colloidal Brilliant Blue G (Sigma). Newly synthesized proteins were detected by fluorography of the same gels.
Immunoprecipitation
Rabbit polyclonal antibodies raised against 72-kD gelatinase, stromelysin, collagenase, TIMP-1, and TIMP-2 were isolated from antisera by use of protein A (PrA)-Sepharose (Sigma) and used to immunoprecipitate 35S-labeled proteins secreted in culture by SMCs. Culture media were incubated with the primary antibodies bound to the PrA-Sepharose gel for 2 hours at room temperature. Nonspecifically bound proteins were removed by four 5-minute washes of the gel with 10 mmol/L sodium phosphate, pH 7.2, containing 150 mmol/L NaCl (PBS) and supplemented with 1% Triton X-100, 0.1% SDS, 0.5% sodium deoxycholate, and 0.2% sodium azide. Controls for nonspecific binding included incubation of culture media with normal rabbit serum, with irrelevant monoclonal antibodies, or directly with PrA-Sepharose. Sequential immunoprecipitation was used to check for the possible crossreaction of the anti-TIMP-1 and -TIMP-2 antibodies. In this case, paired aliquots of culture media from metabolically labeled SMCs were incubated with antibodies raised against one of the TIMPs. In this case, proteins not bound during the first immunoprecipitation were incubated with antibodies raised against the other inhibitor. Immunoprecipitated proteins were eluted by heating of the Sepharose gel at 65°C for 10 minutes in nonreducing SDS-polyacrylamide gel electrophoresis (PAGE) sample buffer and separated by SDS-PAGE. The polyacrylamide gels were fixed, impregnated with EN'HANCE (DuPont-NEN), dried, and exposed to x-ray film at -70°C for detection of immunoprecipitated proteins.
N-Glycosidase Treatment
Metabolically labeled immunoprecipitated stromelysin and TIMP-1 were treated with N-glycosidase F (New England BioLabs) according to the manufacturer's instructions. Duplicates, incubated in the absence of the enzyme, were compared by fluorography with the treated samples.
Immunoblotting
Proteins were transferred from minigels onto nitrocellulose with a semidry blotting system (Bio-Rad Laboratories). An alkaline phosphatase kit (Vector Laboratories) or a chemiluminiscent detection system (Amersham Corp) was used for antigen detection according to the manufacturer's instructions. Blocking of nonspecific binding and dilution of the primary and secondary antibodies were made with a 5% solution of dry defatted milk in PBS containing 0.1% Tween 20.
Northern Blot Analysis RNA, extracted20 after the metabolic labeling of SMCs, was separated in formamide/agarose gels and transferred to Hybond nylon membranes (Amersham Corp). The cDNA and oligonucleotide probes were labeled with [32P]CTP (DuPont-NEN) by use of a random-priming kit (Pharmacia LKB Biotechnology). Probes were hybridized overnight at 42°C and then the nylon membranes were successively washed at 55°C with three changes of 2x standard saline citrate (SSC) and 1% SDS (15, 15 , and 45 minutes), 1 x SSC and 0.1% SDS (1 hour), and 0.5 x SSC and 0.05% SDS (20 minutes) and exposed overnight to x-ray film at -70°C.
Data Analysis
Gels and blots were analyzed by densitometry using the National Institutes of Health IMAGE program version 1.49.
Data were compared by one-way ANOVA.
Immunocytochemistry
The presence of various pro-MMPs and TIMPs in confluent SMCs grown on glass coverslips was detected by simple or double immunofluorescence. After stimulation with cytokines, cells were incubated for 3 hours in the presence of 1 mmol/L monensin to inhibit MMP secretion21 and then fixed with cold acetone. Slides were incubated with 10% normal goat serum in PBS and then with the primary antibodies diluted in 2% goat serum in PBS for 1 to 2 hours. After washing with PBS (three times for 5 minutes), the cells were layered with biotinylated goat anti-rabbit IgG (Vector Laboratories) for 30 minutes. 
Results
Vascular SMCs Constitutively Express 72-kD Gelatinase and May Activate This Enzyme When Exposed to Cytokines
The 72-kD gelatinase (MMP-2) specifically digests nonfibrillar collagens, such as those typically found in the cellular basement membrane, as well as denatured collagen fragments. Invasive behavior of transformed cells correlates with high levels of 72-kD gelatinase expression.23 Unstimulated SMCs constitutively secreted gelatinolytic activity, as revealed by zymography (Fig 1) . This activity comigrated in SDS-PAGE with that released by synovial fibroblasts (Fig 1) and HT 1080 fibrosarcoma cells (data not shown). Lysis of gelatin was completely inhibited by incubation of gels in the presence of EDTA but not with the serine protease inhibitor PMSF, consistent with the MMP nature of the gelatinolytic proteins detected by zymography.
The major zone of gelatinolytic activity in the media harvested from SMCs exposed to various stimuli (Fig 2) comigrated with that from unstimulated cells. This activity has been identified as associated with the 72-kD gelatinase by its immunoprecipitation with specific antibodies (Fig 3, left panel) . The zone of gelatin lysis (Fig Human SMCs treated with TNF-a or IL-1 released additional gelatinolytic activity, which migrated in SDS-PAGE zymography (Fig 2, left gel) more slowly than the constitutively secreted 72-kD gelatinase. Fluorography of the same gel (Fig 2, right gel) showed de novo synthesis of metabolically labeled proteins that comigrated with the gelatinolytic bands contained in the media of stimulated cells. IL-1 induced time-dependent release of this activity (Fig 5) . The cytokine-inducible gelatinolytic band comigrated with a purified preparation of the pro-92-kD gelatinase secreted by TPAstimulated HT 1080 cells (Fig 6) . Anti-92-kD gelatinase antibodies immunoprecipitated this gelatinolytic activity from the media of cytokine-stimulated but not of unstimulated SMCs (Fig 6) Anti-stromelysin polyclonal antibodies immunoprecipitated two proteins synthesized de novo and secreted by IL-I-stimulated cells (Fig 8, left panel) account for different MW values of the two forms. 32 However, treatment of the immunoprecipitate with N-glycosidase F did not modify the apparent MW of either band (Fig 8, right panel) . In the same conditions the N-glycosidase treatment decreased the apparent MW of immunoprecipitated TIMP-1 (data not shown), confirming the efficacy of the deglycosylation treatment. Therefore, the more rapidly migrating species immunoprecipitated by the anti-stromelysin antibodies may represent activated stromelysin. IL-1 stimulation induced accumulation of stromelysin mRNA as well (Fig 9) .
Cytokine-Stimulated SMCs Produce Interstitial Collagenase
Mature interstitial collagens exist in triple helical coils, highly resistant to protease degradation. The interstitial collagenase (MMP-1) can cleave these helical collagen fibrils, producing fragments susceptible to subsequent digestion by the gelatinases. Cytokine-stimulated SMCs released activities compatible with interstitial collagenase, barely detectable by gelatin zymography. Cytokine stimulation of SMCs caused release of collagenase protein, identified by Western blotting (Fig  10) . TNF-a or IL-1 induced the de novo synthesis and secretion of collagenase, as shown by the immunoprecipitation of radiolabeled protein from the supernates of stimulated SMCs (Fig 8) .
SMCs Produce TIMPs
Understanding the matrix-degrading potential of cells also requires consideration of their capacity to The media of unstimulated SMCs contained both TIMP-1 (Fig 8) and TIMP-2 (Fig 11) . The antibody raised against TIMP-2, the specific inhibitor of the 72-kD gelatinase,15,38 coprecipitated the major gelatinolytic protein from SMC-conditioned media. The use of reducing conditions for SDS-PAGE abolished the gelatinolytic activity of the immunoprecipitate and resolved it into two 35S-labeled proteins (Fig liB) that migrated at positions described for the 72-kD gelatinase and TIMP-2.ls539 Therefore, as described for fibroblasts, most of the TIMP-2 protein secreted by SMCs appeared complexed with the 72-kD gelatinase. Various cytokines did not appear to modify substantially the constitutive synthesis of TIMPs (Fig 8) or the mRNA level of TIMP-1 (Fig 4) . 
